Stanhep 25 Heparin Sodium Injection

✅ Prevents blood clots
✅ Reduces clotting risk
✅ Treats thrombosis
✅ Minimizes embolism risk
✅ Improves blood flow

Stanhep 25 contains Heparin Sodium.

Product Overview

Stanhep 25 Injection is a heparin-based anticoagulant medication containing Heparin Sodium as its active ingredient. This injectable blood thinner is clinically used to prevent and treat thrombotic conditions affecting veins, arteries, and pulmonary circulation. Available in multiple dosage strengths, it requires professional medical administration and supervision during treatment.

Therapeutic Applications

This anticoagulant therapy is indicated for thromboembolic prophylaxis and treatment in high-risk patients, including surgical candidates, immobilized individuals, and those with specific cardiovascular conditions. Its clinical applications encompass perioperative clot prevention (cardiac procedures, orthopedic surgeries, dialysis) and management of acute coronary syndromes including myocardial infarction and unstable angina.

Administration Guidelines

Stanhep 25 Injection is parenterally administered via subcutaneous or intravenous routes by qualified healthcare personnel. Dosage regimens are individualized based on therapeutic indication, patient parameters, and treatment response. Proper injection technique regarding site selection and needle depth is crucial for optimal drug absorption. Patients should never self-administer without proper medical training and authorization.

Mechanism of Action

The pharmacologic activity of Heparin Sodium involves potentiation of antithrombin III, an endogenous anticoagulant protein. This molecular interaction significantly accelerates the inhibition of key coagulation factors (particularly thrombin and factor Xa), thereby disrupting the clotting cascade and preventing thrombus formation.

Dosage Protocol

Therapeutic dosing is physician-determined based on comprehensive clinical assessment, including indication-specific requirements, patient weight, and coagulation monitoring. Administration may involve either subcutaneous tissue deposition or intravenous infusion. Strict adherence to prescribed dosing schedules and administration techniques is essential for therapeutic efficacy and safety.

Therapeutic Advantages

This anticoagulant formulation provides critical protection against venous thromboembolism (including DVT and PE) and arterial thrombotic events. Its perioperative application significantly reduces thrombotic complications, while its use in acute coronary syndromes helps maintain vascular patency. The medication supports hemodynamic stability by preserving normal blood rheology.

Adverse Effects

Common treatment-emergent effects include localized injection site reactions (hematoma, ecchymosis), hypersensitivity manifestations, and heparin-induced thrombocytopenia. Potential serious complications include hemorrhagic events, metabolic bone disease with extended therapy, and alopecia. Any abnormal symptoms should receive immediate medical attention.

Precautions and Contraindications

Caution is warranted in patients with hemorrhagic diatheses, active ulcerative conditions, or significant hepatic/renal impairment. Significant drug interactions may occur with NSAIDs, other antithrombotic agents, and certain herbal supplements, potentially exacerbating bleeding risk. Complete medication and medical history disclosure is mandatory prior to therapy initiation.

Storage Requirements

Maintain at controlled room temperature (15-30°C) in light-resistant containers. Ensure proper segregation from pediatric access and household pets. Avoid freezing or temperature extremes. Dispose of unused medication according to biomedical waste protocols.

Medical Disclaimer

The provided information represents expert-reviewed pharmacological data intended for educational purposes only. This content does not encompass all potential adverse effects, contraindications, or drug interactions. It should not substitute professional medical advice, diagnosis, or treatment. Always consult qualified healthcare providers regarding therapeutic decisions. This information aims to facilitate informed patient-physician discussions, not replace clinical judgment.

Strength

25.000 IU/5ml

Quantity

1 Vial/s, 2 Vial/s, 3 Vial/s, 10 Vial/s

Reviews

There are no reviews yet

Add a review
Stanhep 25 Heparin Sodium Injection Stanhep 25 Heparin Sodium Injection
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot